Spots Global Cancer Trial Database for pcnsl
Every month we try and update this database with for pcnsl cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL) | NCT04253496 | Primary Central... | Tumor samples a... | 60 Years - | Assistance Publique - Hôpitaux de Paris | |
| Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma | NCT05021770 | Refractory and ... PCNSL Non Hodgkin Lym... | Orelabrutinib Orelabrutinib Thiotepa | 18 Years - | Sun Yat-sen University | |
| Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma | NCT00712062 | Primary Central... | Pemetrexed | 18 Years - | University of Florida | |
| Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma | NCT02934204 | Primary CNS Lym... | methotrexate temozolomide | 18 Years - 75 Years | Guangdong Provincial People's Hospital | |
| A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL | NCT04438044 | PCNSL Secondary Centr... | ICP-022 | 18 Years - 75 Years | Beijing InnoCare Pharma Tech Co., Ltd. | |
| Diagnosis; Objective RespOnse; THErApy | NCT05036564 | Primary CNS Lym... | Lumbar puncture | 18 Years - | IRCCS San Raffaele | |
| Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma | NCT02934204 | Primary CNS Lym... | methotrexate temozolomide | 18 Years - 75 Years | Guangdong Provincial People's Hospital | |
| Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL) | NCT04253496 | Primary Central... | Tumor samples a... | 60 Years - | Assistance Publique - Hôpitaux de Paris | |
| Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma | NCT04514393 | Primary Central... PCNSL Non Hodgkin Lym... | Methotrexate Ibrutinib Temozolomide | 18 Years - 70 Years | Sun Yat-sen University | |
| Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma | NCT01458730 | Central Nervous... | Immunochemother... | 18 Years - 75 Years | University of Aarhus | |
| Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma | NCT00193973 | Primary Central... | Idarubicin, Met... Radiation Thera... | 18 Years - 70 Years | Trans Tasman Radiation Oncology Group | |
| Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma | NCT02934204 | Primary CNS Lym... | methotrexate temozolomide | 18 Years - 75 Years | Guangdong Provincial People's Hospital | |
| A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL | NCT04438044 | PCNSL Secondary Centr... | ICP-022 | 18 Years - 75 Years | Beijing InnoCare Pharma Tech Co., Ltd. | |
| Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL | NCT03212807 | EBV Related Non... Primary CNS Lym... Primary Testicu... | Durvalumab Lenalidomide | 21 Years - 80 Years | Singapore General Hospital | |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System | NCT05211336 | Primary Diffuse... Aggressive B-ce... | Obinutuzumab Prednisone Lenalidomide Venetoclax Ibrutinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System | NCT03495960 | Primary Central... | Rituximab Methotrexate Procarbazine Lenalidomide Radiotherapy Temozolomide | 70 Years - | International Extranodal Lymphoma Study Group (IELSG) | |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System | NCT05211336 | Primary Diffuse... Aggressive B-ce... | Obinutuzumab Prednisone Lenalidomide Venetoclax Ibrutinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma | NCT03328078 | Relapsed Hemato... Refractory Hema... Relapsed Primar... Refractory Prim... | Emavusertib ibrutinib | 18 Years - | Curis, Inc. | |
| Diagnosis; Objective RespOnse; THErApy | NCT05036564 | Primary CNS Lym... | Lumbar puncture | 18 Years - | IRCCS San Raffaele |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
